Nicotinamide Adenine Dinucleotide Market size to exceed $1.4Bn by 2030

Nicotinamide Adenine Dinucleotide Market size is anticipated to exceed USD 1.4 billion by 2030, as per a new research report announced by Global Market Insights Inc.
 

Growing awareness regarding NAD’s benefits in boosting metabolism as well as the rising consumer demand for anti-aging products as the chief drivers of the nicotinamide adenine dinucleotide industry. Prominent research projects in the field to explore the significance of NAD for human health are fostering product outlook. For instance, in September 2022, the research team from Griffith University aimed to study bacterial enzymes that split NAD and produce new signaling molecules that can impact immune responses.
 

Notable research and diagnostic utilization to increase others segment share

With respect to grade, nicotinamide adenine dinucleotide market into food grade, pharmaceutical grade, and others. The others grade segment valuation was recorded at USD 150 million in 2021 and is expected to grow at an 11.5% CAGR between 2022 and 2030. The others segment includes NAD utilized in lab chemicals for research and diagnostic applications. NAD serves as an essential cofactor for various redox reactions as a research and laboratory enzyme, which is fueling its utilization in varied diagnostic tests, including those that quantify ethanol and lactate dehydrogenase.
 

Surging adoption of supplementation to augment dietary supplements segment expansion

The use of nicotinamide adenine dinucleotide in the form of dietary supplements is set to remain high over the next 8 years. The NAD market share from the dietary supplements application segment was valued at over USD 175 million in 2021 and is anticipated to observe strong progress through 2030. The soaring acceptance of supplementation and functional products has bolstered nutritional supplement demand. This is fueling the penetration of NAD supplements that are known to increase the circulation of NAD+ in the bloodstream, which is speculated to push product adoption in dietary supplements.
 

Browse key industry insights spread across 250 pages with 156 market data tables & 22 figures & charts from the report, “Nicotinamide Adenine Dinucleotide Market Size By Grade (Food grade, Pharmaceutical grade), Application (Dietary supplements, Pharmaceuticals, Anti-aging Products), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/nicotinamide-adenine-dinucleotide-market
 

Escalating nutritional prominence of NAD to positively influence APAC industry

Asia Pacific nicotinamide adenine dinucleotide market is projected to depict steady CAGR of more than 13.5% CAGR over 2022-2030. The region may emerge as a major hub for this industry owing to the wide applicability of NAD in manufacturing nutrition and supplementation together with its growing adoption in the pharma sector. Additionally, increasing demand for improving immunization to chronic diseases, along with the strong presence of market players, is estimated to stimulate regional market growth.
 

Product launches to remain a key growth strategy

The strategic landscape of the nicotinamide adenine dinucleotide industry is slated to witness a series of product innovation projects, strategic collaborations, mergers, acquisitions, and partnerships by industry players. Some of the key nicotinamide adenine dinucleotide market players profiled in the report include Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., F. Hoffmann-La Roche Ltd, HiMedia Laboratories, NutriScience Innovations, LLC, Nutrifoods, Bontac Bio-engineering (Shenzhen) Co., Ltd., Krackeler Scientific, Shandong Lankang Bio-Technology Co., Ltd., and OYC Americas, Inc., among others.